Safety Alerts and Recalls

Safety Alerts & Recalls

Numerous Injectable Products Recalled Due to Foreign Matter

Mylan announced a voluntary recall of multiple injectable products due to the potential presence of visible foreign particulate matter.

FDA, Manufacturers Battling Over BMPEA

The Food and Drug Administration (FDA) has issued warning letters to five manufacturers of dietary supplements due to the listing of R-beta-methylphenethylamine (also known as Beta-methylphenethylamine, βMePEA, or BMPEA) on the product label.

Recall Issued for Ebola Virus One-Step Test Kits

The Food and Drug Administration (FDA) has issued a Class 1 recall for the Ebola Virus One-Step Test Kits (LuSys Laboratories). This test kit has not been cleared or approved by the FDA for in vitro diagnostic detection of Ebola Virus infection.

Norpace CR Still in Shortage, Anticipated Availability Announced

The Food and Drug Administration (FDA) announced that Norpace CR (disopyramide phosphate; Pfizer) controlled-release 100mg is currently in shortage.

FDA: Hypertension Tx Currently in Shortage

The Food and Drug Administration (FDA) announced that Bystolic (nebivolol; Forest Laboratories) 20mg is currently in shortage.

Recall of OTC Cold/Flu Medicine Due to Mislabeling Initiated

RB (formerly Reckitt Benckiser) announced a voluntary recall of certain lots of liquid bottles of over-the-counter (OTC) Mucinex Fast-Max due to mislabeling of drug facts.

New Warning From FDA on Unapproved Drugs in Sex Enhancement Supplement

The Food and Drug Administration (FDA) is warning consumers to not buy or use Extreme Diamond 3000, a product promoted and sold for sexual enhancement.

FDA: Topical Flurbiprofen Exposure May Be Fatal for Pets

The FDA is warning pet owners, veterinarians, healthcare providers, and pharmacists that pets are at risk of illness and death when exposed to topical pain medications containing flurbiprofen.

Counterfeit Botox Discovered in the U.S.

The FDA is alerting healthcare providers and the public that counterfeit Botox (onabotulinumtoxin A; Allergan) has been found in the United States and may have been distributed to doctors' offices and clinics.

FDA Issues New Warning for "Bo Ying Compound"

The FDA continues to warn consumers and caregivers not to use Eu Yan Sang (Hong Kong) Ltd.'s "Bo Ying compound" because of the possible lead poisoning risk associated with the product.